Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis

Isolated leptomeningeal recurrence of melanoma is rare, occurring in 2% of patients with central nervous system involvement secondary to melanoma. The optimal treatment of leptomeningeal carcinomatosis (LMC) in melanoma has not yet been determined and remains a major challenge. We report a melanoma...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Case Reports in Oncology
المؤلفون الرئيسيون: Andreas F. Hottinger, Laurence Favet, Jean-Claude Pache, Jean-Baptiste Martin, Pierre-Yves Dietrich
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Karger Publishers 2011-04-01
الموضوعات:
Leptomeningeal carcinomatosis
Delayed response
Melanoma
Temozolomide
الوصول للمادة أونلاين:http://www.karger.com/Article/FullText/327699

الانترنت

http://www.karger.com/Article/FullText/327699

مواد مشابهة